Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001683168-26-004591
Filing Date
2026-06-05
Accepted
2026-06-05 16:54:30
Documents
16
Effectiveness Date
2026-06-05

Document Format Files

Seq Description Document Type Size
1 FORM S-8 valion_s8-velocity.htm S-8 72388
2 OPINION valion_ex0501.htm EX-5.1 12779
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM valion_ex2301.htm EX-23.1 2017
4 FORM OF STOCK OPTION GRANT NOTICE INDUCEMENT GRANT valion_ex9901.htm EX-99.1 79250
5 FILING FEE IXBRL valion_ex107.htm   iXBRL EX-FILING FEES 31800
6 GRAPHIC image_001.jpg GRAPHIC 6820
  Complete submission text file 0001683168-26-004591.txt   382573

Data Files

Seq Description Document Type Size
19 EXTRACTED XBRL INSTANCE DOCUMENT valion_ex107_htm.xml XML 14605
Mailing Address 1305 E. HOUSTON STREET BUILDING 1, SUITE 311 SAN ANTONIO TX 78205
Business Address 1305 E. HOUSTON STREET BUILDING 1, SUITE 311 SAN ANTONIO TX 78205 (888)276-6888
Valion Bio, Inc. (Filer) CIK: 0001787740 (see all company filings)

EIN.: 814016391 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-296561 | Film No.: 261069975
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)